Desjardins, A., Gromeier, M., Friedman, H., Landi, D., Friedman, A., Ashley, D. M., … Bigner, D. (2021). SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS. In NEURO-ONCOLOGY (Vol. 23, pp. 97–97).

Desjardins, Annick, Matthias Gromeier, Henry Friedman, Daniel Landi, Allan Friedman, David M. Ashley, William Curry, et al. “SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS.” In NEURO-ONCOLOGY, 23:97–97, 2021.

Desjardins A, Gromeier M, Friedman H, Landi D, Friedman A, Ashley DM, et al. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS. In: NEURO-ONCOLOGY. 2021. p. 97–97.

Desjardins, Annick, et al. “SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS.” NEURO-ONCOLOGY, vol. 23, 2021, pp. 97–97.

Desjardins A, Gromeier M, Friedman H, Landi D, Friedman A, Ashley DM, Curry W, Butowski N, Sloan A, Wen P, Cavaliere R, Gerstner E, Berger M, Buerki R, Chiocca EA, Sauvageau E, Kelly A, Nichols WG, Mixson L, Dickinson A, Orr K, Learn C, Bigner D. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS. NEURO-ONCOLOGY. 2021. p. 97–97.